CC
MTEM

Caxton Corporation’s Molecular Templates, Inc. MTEM Stock Holding History

Caxton Corporation’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-136,866
Closed -$157K – 13
2024
Q2 		$157K Hold
136,866
– – 0.8% 9
2024
Q1 		$307K Hold
136,866
– – 1.75% 6
2023
Q4 		$511K Hold
136,866
– – 2.76% 5
2023
Q3 		$865K Hold
136,866
– – 3.29% 4
2023
Q2 		$985K Hold
136,866
– – 2.84% 4
2023
Q1 		$780K Hold
136,866
– – 1.97% 8
2022
Q4 		$673K Hold
136,866
– – 1.72% 12
2022
Q3 		$1.54M Hold
136,866
– – 2.89% 8
2022
Q2 		$1.87M Hold
136,866
– – 2.51% 8
2022
Q1 		$7.08M Sell
136,866
-5,667
-4% -$250K 8.81% 5
2021
Q4 		$8.38M Hold
142,533
– – 6.85% 5
2021
Q3 		$14.3M Hold
142,533
– – 11.63% 3
2021
Q2 		$16.7M Buy
142,533
+1,000
+0.7% +$131K 11.46% 2
2021
Q1 		$26.8M Hold
141,533
– – 17.4% 1
2020
Q4 		$19.9M Hold
141,533
– – 12.43% 2
2020
Q3 		$23.2M Buy
141,533
+1,000
+0.7% +$178K 21.86% 2
2020
Q2 		$29.1M Hold
140,533
– – 30.68% 1
2020
Q1 		$28M Buy
140,533
+1,000
+0.7% +$219K 30.63% 1
2019
Q4 		$29.3M Buy
139,533
+31,250
+29% +$4.49M 28.23% 1
2019
Q3 		$10.7M Hold
108,283
– – 12.07% 3
2019
Q2 		$13.6M Hold
108,283
– – 15.4% 2
2019
Q1 		$9.44M Hold
108,283
– – 8.76% 4
2018
Q4 		$6.56M Buy
108,283
+1,667
+2% +$116K 7.96% 5
2018
Q3 		$8.62M Buy
106,616
+36,364
+52% +$2.79M 7.97% 5
2018
Q2 		$5.51M Buy
70,252
+1,000
+1% +$113K 1.95% 6
2018
Q1 		$8.31M Buy
69,252
+1,666
+2% +$251K 9.02% 3
2017
Q4 		$10.2M Hold
67,586
– – 12.35% 2
2017
Q3 		$7.07M Buy
+67,586
New +$5.84M 7.19% 6

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
I
INVST Indianapolis, Indiana $1.03B AUM 29.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Caxton Corporation's MTEM Position: Q3 2024 in Review

Caxton Corporation sold out of Molecular Templates, Inc. (MTEM) in Q3 2024, closing a stake of 136,866 shares — an estimated $157K sold.

Caxton Corporation first reported a position in MTEM in Q3 2017 and held it in 28 quarters. The position peaked at $29.3M in Q4 2019. 24 funds tracked by Wall St. Rank hold MTEM as of Q3 2024.

  • Caxton Corporation reported no remaining Molecular Templates, Inc. position as of Q3 2024 after selling out during the quarter.
  • Caxton Corporation sold 136,866 Molecular Templates, Inc. shares in Q3 2024, an estimated $157K.
  • Caxton Corporation first reported a position in Molecular Templates, Inc. in Q3 2017 and held it in 28 quarters.
  • Caxton Corporation's Molecular Templates, Inc. position peaked at $29.3M in Q4 2019.
  • 24 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2024.

Based on Caxton Corporation's 13F filing for Q3 2024, filed 14 Nov 2024.